Zealand Pharma A/S
ZLDPF
$46.38
-$1.27-2.66%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 598.45M | -60.50M | -59.09M | -63.32M | 1.15B |
| Total Depreciation and Amortization | 1.37M | 1.54M | 719.50K | 1.13M | 1.06M |
| Total Amortization of Deferred Charges | 305.50K | -- | 3.18M | -- | -- |
| Total Other Non-Cash Items | 2.60M | -1.23M | -189.20M | 18.46M | 75.45M |
| Change in Net Operating Assets | -540.72M | -42.99M | 81.85M | -25.78M | 67.54M |
| Cash from Operations | 62.01M | -103.18M | -162.54M | -69.52M | 1.30B |
| Capital Expenditure | -1.99M | -1.54M | -2.63M | -570.80K | -1.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.05M | -16.28M | -55.58M | -133.43M | -238.51M |
| Cash from Investing | 34.06M | -17.81M | -58.21M | -134.00M | -239.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.00M | -9.00M | -5.98M | -5.42M | -5.00M |
| Issuance of Common Stock | 11.00M | 1.00M | 16.62M | 1.90M | 27.00M |
| Repurchase of Common Stock | -438.00M | -- | -- | -74.76M | -332.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -66.44M | -1.23M | 1.66M | -12.26M | -47.16M |
| Foreign Exchange rate Adjustments | -763.70K | 10.44M | 1.47M | 16.63M | -25.40M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.87M | -111.78M | -217.61M | -199.15M | 983.87M |